Application 761444

Type
BLA
Sponsor
SHANGHAI HENLIUS BIOTECH

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761444Bildyosdenosumab-nxxp351(k) InterchangeableRx2026-08-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BILDYOSDENOSUMAB-NXXPINJECTABLE;INJECTION60MG/MLNoNo
002BILPREVDADENOSUMAB-NXXPINJECTABLE;INJECTION120MG/1.7ML(70MG/ML)NoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BILDYOSDENOSUMABOrganon LLCb9e32bf7-d70a-4083-8577-c15751c7f7692026-08-18Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA761444
BilprevdaDENOSUMABOrganon LLCb1f0590e-f5bb-44ac-99a0-4aa4596c7e542026-08-18Warnings, Adverse reactionsExact identifier
application number: BLA761444

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84425ORIG 2025-12-15
84424ORIG 2025-12-15
84000ORIG 2025-11-21
83669ORIG 2025-11-21
84023ORIG 2025-10-31
84022ORIG 2025-10-31
83676ORIG 2025-10-07